Delivering HOPE (Helping Women Optimize Prenatal Equity)
Launched by UNIVERSITY OF ARKANSAS · Feb 6, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Delivering HOPE trial is studying whether providing healthy food to pregnant women can help them maintain a healthy weight during pregnancy. The researchers want to see if giving women money to buy nutritious foods, along with standard nutrition advice and support services, can reduce the number of women who gain too much weight while pregnant. They will compare two groups of women: one group will receive the usual support for healthy eating and weight gain, while the other group will receive the same support plus financial help specifically for healthy food purchases.
To participate in this study, women need to be between 16 and 44 years old, less than 18 weeks pregnant, and able to speak English, Spanish, or Marshallese. The trial is not yet recruiting participants, but once it starts, about 1,440 women will be involved. Participants can expect to receive guidance on nutrition and weight gain, as well as assistance in accessing programs that provide food support. This trial aims to help improve the health of mothers and their babies by promoting healthier eating during pregnancy.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Aged 16-44 years
- • ≤18 weeks pregnant
- • Speak English, Spanish, or Marshallese
About University Of Arkansas
The University of Arkansas is a leading research institution dedicated to advancing healthcare through innovative clinical trials. With a commitment to excellence in research and education, the university facilitates a collaborative environment that encourages interdisciplinary studies and the development of cutting-edge therapies. Its clinical trial programs leverage state-of-the-art facilities and expert faculty, aiming to improve patient outcomes and contribute to the body of medical knowledge. The university fosters partnerships with healthcare providers and industry stakeholders, ensuring rigorous ethical standards and adherence to regulatory requirements in all research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported